Iron Triangle Partners’s Guardant Health GH Stock Holding History

Iron Triangle Partners’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-400,000	Closed	-$25M	–	35
2025 Q3	$25M	Buy	400,000 +100,000	+33%	+$5.44M	3.55%	14
2025 Q2	$15.6M	Sell	300,000 -300,867	-50%	-$13.4M	2.4%	20
2025 Q1	$25.6M	Buy	+600,867	New	+$25.9M	4.03%	11
2022 Q4	–	Sell	-487,193	Closed	-$26.2M	–	29
2022 Q3	$26.2M	Sell	487,193 -503,375	-51%	-$25.8M	4.58%	8
2022 Q2	$40M	Buy	990,568 +268,442	+37%	+$13.3M	5.18%	5
2022 Q1	$47.8M	Buy	722,126 +281,871	+64%	+$19.3M	5.69%	3
2021 Q4	$44M	Buy	440,255 +250,255	+132%	+$25.9M	6.14%	3
2021 Q3	$23.8M	Sell	190,000 -160,000	-46%	-$19M	3.41%	11
2021 Q2	$43.5M	Buy	350,000 +250,000	+250%	+$33.6M	4.48%	11
2021 Q1	$15.3M	Sell	100,000 -66,000	-40%	-$9.97M	1.94%	20
2020 Q4	$21.4M	Hold	166,000	–	–	2.77%	16
2020 Q3	$18.6M	Buy	166,000 +500	+0.3%	+$45.7K	4.15%	12
2020 Q2	$13.4M	Buy	165,500 +125,500	+314%	+$10.1M	3.38%	14
2020 Q1	$2.78M	Sell	40,000 -104,378	-72%	-$8.01M	1.08%	26
2019 Q4	$11.3M	Buy	+144,378	New	+$10.4M	2.99%	17

Other funds holding GH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Iron Triangle Partners's GH Position: Q4 2025 in Review

Iron Triangle Partners sold out of Guardant Health (GH) in Q4 2025, closing a stake of 400,000 shares — an estimated $25M sold.

Iron Triangle Partners first reported a position in GH in Q4 2019 and held it in 15 quarters. The position peaked at $47.8M in Q1 2022. 495 funds tracked by Wall St. Rank hold GH as of Q4 2025.

Iron Triangle Partners reported no remaining Guardant Health position as of Q4 2025 after selling out during the quarter.
Iron Triangle Partners sold 400,000 Guardant Health shares in Q4 2025, an estimated $25M.
Iron Triangle Partners first reported a position in Guardant Health in Q4 2019 and held it in 15 quarters.
Iron Triangle Partners's Guardant Health position peaked at $47.8M in Q1 2022.
495 funds tracked by Wall St. Rank held Guardant Health as of Q4 2025.

Based on Iron Triangle Partners's 13F filing for Q4 2025, filed 17 Feb 2026.